Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jul;33(7):955-64.
doi: 10.1007/s00345-015-1561-0. Epub 2015 May 6.

Histological outcomes after focal high-intensity focused ultrasound and cryotherapy

Taimur T Shah  1 , Veeru Kasivisvanathan, Charles Jameson, Alex Freeman, Mark Emberton, Hashim U Ahmed
Affiliations
Review

Histological outcomes after focal high-intensity focused ultrasound and cryotherapy

Taimur T Shah et al. World J Urol. 2015 Jul.

Abstract

Introduction: Focal therapy has increasingly become an accepted treatment option for patients with localised prostate cancer. Most follow-up protocols use a mixture of protocol biopsies or "for cause" biopsies triggered by a rising PSA. In this paper, we discuss the histological outcomes from these biopsies and their use in guiding subsequent management and trial development.

Methods: We conducted a literature search and reviewed the post-treatment biopsy results from studies on focal HIFU and focal cryotherapy. We subsequently reviewed the results of three recently published consensus statements released discussing many of the issues concerning focal therapy.

Results: Research suggests that 1 in 5 of all post-treatment biopsies after focal therapy are positive. However, the majority of these seemed to be from the untreated portion of the gland or met criteria for clinically insignificant disease. The histological outcomes from focal therapy are promising and confirm its effectiveness in the short to medium term. Furthermore re-treatment is possible whilst maintaining a low-side-effect profile.

Conclusion: Debate is ongoing about the clinical significance of various levels of residual disease after focal therapy and the exact threshold at which to call failure within a patient who has had focal therapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Left image shows a Gleason 3 + 4 adenocarcinoma, middle image shows typical changes after HIFU with no discernible glands, viable cells or tumour with presence of fibrosis and elastotic collagen, right image shows recurrent adenocarcinoma after HIFU
See this image and copyright information in PMC

References

    1. FDA (2014) Executive summary: Ablatherm® integrated imaging high intensity focused ultrasound (HIFU). Meeting of the Gastroenterology and Urology Devices Panel. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMateria...
    1. Valerio M, Emberton M, Ahmed HU. Re: Jarow et al: Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop (Urology 2014;83:975–979) Urology. 2014;84(3):732–733. doi: 10.1016/j.urology.2014.06.007. - DOI - PubMed
    1. Ward JF, Jones JS. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) registry. BJU Int. 2012;109(11):1648–1654. doi: 10.1111/j.1464-410X.2011.10578.x. - DOI - PubMed
    1. Ahmed HU. The index lesion and the origin of prostate cancer. N Engl J Med. 2009;361(17):1704–1706. doi: 10.1056/NEJMcibr0905562. - DOI - PubMed
    1. Ahmed HU, et al. Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol. 2012;13(11):e509–e517. doi: 10.1016/S1470-2045(12)70388-1. - DOI - PubMed

Publication types